1-(2-Chloro-benzyl)-piperidin-4-ylamine hydrochloride, 1g

GC capillary column ROTI®Cap-1701 MS, 30 m, 0.32 mm, 0.50 µm, 1 Piece(s)

[3-(3-methyl-1,2,4-oxadiazol-5-yl)propyl]amine hydrochloride, 95.0%, 2.5g

2-BROMO-N-CYCLOPROPYL-N-METHYLACETAMIDE, 95.0%, 250mg

5-Bromohex-1-ene, 95+%, 1g

(4-Fluorophenyl)(pyrrolidin-1-yl)methanone, 95.0%, 25g

3,5-Difluoro-4-nitrobenzonitrile, 95.0%, 100g

2-(2-Ethoxy-4-formylphenoxy)-N-ethylacetamide, 95%, 1g

4-Isobutylbenzaldehyde>95.0%(GC)500mL

1-(5-Bromopyridin-2-yl)-2,2,2-trifluoroethanol, 97%, 250mg

ETHYL 3-METHYL-2-NITRO-3H-IMIDAZOLE-4-CARBOXYLATE, 97.0%, 1g

1-(2-Amino-4-ethylthiazol-5-yl)ethanone, 97%, 100mg

2-Methyl-2-thiophen-3-yl-propionic acid methyl ester, 97%, 100mg